Sinopharm Group Co Ltd
HKEX:1099
Sinopharm Group Co Ltd
Operating Income
Sinopharm Group Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinopharm Group Co Ltd
HKEX:1099
|
Operating Income
¥22.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Operating Income
¥8.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Operating Income
¥3.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Operating Income
¥2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
21%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Operating Income
¥3.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Operating Income
¥2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
See Also
What is Sinopharm Group Co Ltd's Operating Income?
Operating Income
22.9B
CNY
Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Operating Income amounts to 22.9B CNY.
What is Sinopharm Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%
Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Sinopharm Group Co Ltd have been 10% over the past three years , 10% over the past five years , and 16% over the past ten years .